Adverse Mucocutaneous Reaction to Pertuzumab in a Patient with HER2-Positive Metastatic Breast Cancer

被引：2
|
作者：
Kowalczyk, Lidia [1 ]
Singer, Christian F. [2 ]
Staudigl, Christine [2 ]
Weber, Myriam [2 ]
Farr, Alex [2 ]
机构：
[1] Univ Vet Med, Clin Unit Anesthesiol & Perioperat Intens Care Me, Vienna, Austria
[2] Med Univ Vienna, Dept Obstet & Gynecol, Ctr Breast Hlth, Waehringer Guertel 18-20, A-1090 Vienna, Austria
来源：
BREAST JOURNAL | 2017年 / 23卷 / 03期
关键词：
D O I：
10.1111/tbj.12676
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352 / 353
页数：2
相关论文
共 50 条
  • [41] Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
    Luai S. Al Rabadi
    Madeline M. Cook
    Andy J. Kaempf
    Megan M. Saraceni
    Michael A. Savin
    Zahi I. Mitri
    BMC Cancer, 21
  • [42] Comparing pyrotinib with trastuzumab and pertuzumab with trastuzumab for HER2-positive metastatic breast cancer: a retrospective, multicenter analysis
    You, Shuhui
    Xie, Yizhao
    Sang, Die
    Luo, Ting
    Yuan, Peng
    Xu, Fei
    Wang, Biyun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [43] Treatment of HER2-Positive Metastatic Breast Cancer REPLY
    Swain, Sandra M.
    Clark, Emma
    Baselga, Jose
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (20): : 1964 - 1965
  • [44] Therapy for HER2-Positive Metastatic Breast Cancer REPLY
    Winer, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):
  • [45] HER2-positive metastatic breast cancer: A changing scenario
    Mustacchi, G.
    Biganzoli, L.
    Pronzato, P.
    Montemurro, F.
    Dambrosio, M.
    Minelli, M.
    Molteni, L.
    Scaltriti, L.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 95 (01) : 78 - 87
  • [46] Overcoming resistance in Her2-positive metastatic breast cancer
    Oksuzoglu, Omur Berna
    LEUKEMIA RESEARCH, 2018, 73 : S13 - S13
  • [47] Updates in Treatment of HER2-positive Metastatic Breast Cancer
    Avelino, Alzira R. M.
    Pulipati, Soumya
    Jamouss, Kevin
    Bhardwaj, Prarthna V.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (12) : 1471 - 1481
  • [48] Trastuzumab emtansine in HER2-positive metastatic breast cancer
    Montemurro, Filippo
    LANCET ONCOLOGY, 2017, 18 (06): : 696 - 697
  • [49] The changing treatment of metastatic her2-positive breast cancer
    Mitsogianni, Maria
    Trontzas, Ioannis P.
    Gomatou, Georgia
    Ioannou, Stephanie
    Syrigos, Nikolaos K.
    Kotteas, Elias A.
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [50] HER2-Positive Metastatic Breast Cancer: A Comprehensive Review
    Exman, Pedro
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 40 - 50
12345